sdea

The Pharmacovigilance Audit of a business partner can be tricky, as there may be direct or indirect commercial implications associated with the audit’s outcome. A business partner can be a distributor, wholesaler, or service provider. For the scope of this article, we will primarily focus on product distributors. There can be multiple business partners in […]

It is not feasible for pharmaceutical companies to have subsidiaries, affiliates, vendors, or even employees in every country they operate or hold licenses. One that it may not be cost-effective, or the local requirements (regulations/ business policies) may make it difficult to manage them. At times, it may be necessary to have business arrangements even […]

Not all companies would consider setting up affiliate offices/ subsidiaries in all countries where they wish to operate or commercialize products. The Pharma company may consider nominating a distributor or business partner in such scenarios. Besides, companies may even consider co-marketing arrangements in countries already operating, using own-label or private-label supplies or other means such […]